You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 22, 2025

Details for Patent: 11,925,695


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,925,695
Title:Methods for making ultrasound contrast agents
Abstract:Provided herein are improved methods for preparing phospholipid formulations including phospholipid UCA formulations.
Inventor(s):Simon P. Robinson, Robert W. Siegler, Nhung Tuyet Nguyen, David C. Onthank, Tarakeshwar Vishwanath Anklekar, Charles Chester Van Kirk
Assignee:Lantheus Medical Imaging Inc
Application Number:US18/321,714
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 11,925,695

Introduction

Patent 11,925,695, like any other patent, is a complex document that outlines the invention, its scope, and the claims made by the inventor. To analyze this patent, we need to delve into several key aspects, including the patent's subject matter, the claims, and the broader patent landscape.

Subject Matter Eligibility

Subject matter eligibility is a critical factor in determining the validity and scope of a patent. The USPTO's 2024 guidance update on AI patent eligibility provides valuable insights into how subject matter eligibility is assessed.

Judicial Exceptions and Practical Applications

The 2024 USPTO guidance emphasizes the importance of integrating judicial exceptions into practical applications to ensure patent eligibility. For a claim to be patent-eligible, it must impose meaningful limits on the judicial exception, transforming it into a practical application. This is particularly relevant for patents involving AI or other technologies that may encompass abstract ideas or mathematical calculations[4].

Patent Claims

The claims section of a patent is where the inventor specifies what they are seeking to protect. Here are some key points to consider:

Independent Claim Length and Count

Research has shown that the length and count of independent claims can be metrics for measuring patent scope. Patents with narrower claims, as indicated by shorter independent claim lengths and lower independent claim counts, tend to have a higher probability of grant and a shorter examination process[3].

Claim Specificity

Claims must be specific and clear to avoid issues of overbreadth and lack of clarity. The specificity of claims, such as detailing the use of an invention in a particular application, can make the claim more patent-eligible by adding practical utility[4].

Patent Scope

Patent scope is a crucial aspect that determines the breadth of protection granted to the inventor.

Metrics for Measuring Patent Scope

Independent claim length and count are simple yet effective metrics for measuring patent scope. These metrics have explanatory power for various correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

Narrowing of Claims During Examination

The examination process often narrows the scope of patent claims. This narrowing can be significant, especially when the examination duration is longer. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Patent Term Adjustments (PTA) and Terminal Disclaimers

Understanding how patent term adjustments and terminal disclaimers affect the patent's expiration date is essential.

Patent Term Adjustments

PTA is granted to compensate for delays in the patent prosecution process. However, the Board has held that any ODP (Obviousness-Type Double Patenting) analysis or determination should be based on the adjusted expiration date of the patent, including any PTA granted[1].

Terminal Disclaimers

Terminal disclaimers are often used to overcome ODP rejections. The Board has ruled that the term of a patent with a terminal disclaimer cannot be adjusted beyond the specified date in the disclaimer. This means that PTA does not extend the term of a patent past the date of a terminal disclaimer[1].

Patent Landscape and Expiration Dates

The patent landscape includes various factors such as the expiration dates of related patents, the presence of similar patents, and the regulatory environment.

Expiration Dates

For Patent 11,925,695, understanding its expiration date is crucial. This date can be influenced by PTA and terminal disclaimers. The expiration date listed in databases like the FDA Orange Book can provide insights into when the patent protection will end[5].

Regulatory Environment

The regulatory environment, including updates from the USPTO and court rulings, can significantly impact the patent landscape. For instance, the 2024 USPTO guidance on AI patents clarifies how AI-assisted inventions are evaluated, ensuring they are treated on equal footing with other technologies[4].

Small Claims Patent Courts

The concept of small claims patent courts is being explored to address issues related to patent litigation costs and accessibility.

Feasibility and Structure

Studies by ACUS have examined the feasibility and potential structure of a small claims patent court. This includes addressing legal, policy, and practical considerations to ensure that such a court would be effective and fair for all stakeholders[2].

Key Takeaways

  • Subject Matter Eligibility: Claims must integrate judicial exceptions into practical applications to be patent-eligible.
  • Patent Claims: Narrower claims with specific applications tend to have a higher probability of grant and shorter examination processes.
  • Patent Scope: Independent claim length and count are useful metrics for measuring patent scope.
  • PTA and Terminal Disclaimers: PTA and terminal disclaimers can significantly affect the patent's expiration date.
  • Patent Landscape: Understanding expiration dates and the regulatory environment is crucial for navigating the patent landscape.

FAQs

Q: What is the significance of integrating judicial exceptions into practical applications in patent claims? A: Integrating judicial exceptions into practical applications is essential for ensuring that the claim is patent-eligible. This involves adding meaningful limits to the claim, transforming it into a practical application[4].

Q: How do independent claim length and count affect the patent examination process? A: Narrower claims, as indicated by shorter independent claim lengths and lower independent claim counts, are associated with a higher probability of grant and a shorter examination process[3].

Q: What is the impact of PTA on the expiration date of a patent with a terminal disclaimer? A: PTA does not extend the term of a patent past the date specified in a terminal disclaimer. Any ODP analysis must consider the adjusted expiration date including PTA[1].

Q: How does the regulatory environment influence the patent landscape? A: Updates from the USPTO, such as the 2024 guidance on AI patents, and court rulings can significantly impact how patents are evaluated and protected. This affects the overall patent landscape and how inventors and practitioners navigate it[4].

Q: What is the purpose of exploring the concept of a small claims patent court? A: The purpose is to address issues related to patent litigation costs and accessibility, making it easier and more affordable for inventors to protect their intellectual property[2].

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1]
  2. U.S. Patent Small Claims Court - Administrative Conference of the United States[2]
  3. Patent Claims and Patent Scope - SSRN[3]
  4. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz[4]
  5. US Patent 11925695 - PharmaCompass[5]

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,925,695

Showing 1 to 2 of 2 entries

International Family Members for US Patent 11,925,695

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2017291815 ⤷  Try for Free
Brazil 112018074469 ⤷  Try for Free
Canada 3025580 ⤷  Try for Free
China 109562194 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.